Spero Therapeutics
Spero Therapeutics is a Massachusetts-based biopharmaceutical company that develops novel therapeutics for the treatment of bacterial and urinary tract infections.
Business Model:
Revenue: $8.8M
Employees: 51-200
Industries / Tags:
Detailed Spero Therapeutics Information
Geographic Data
Address: 675 Massachusetts Avenue
City: Cambridge
State: MA
Zip: 02139
Country: US
Financial Info
Stage:
grant
Raised Last:
$13M
Raised Total:$435M
Social
Metrics
1,594,066Website Global Rank
15,414Website Monthly Traffic
Twitter Followers
Description
Spero Therapeutics is a Massachusetts-based biopharmaceutical company that develops novel therapeutics for the treatment of bacterial and urinary tract infections.
Contact Phone:
+18572421600
Contact Email:
Spero Therapeutics went public on 11/2/2017 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
11/2/2017
IPO Valuation:
$194M
Ticker Symbol:
SPRO
IPO Price:
$14/share
Amount Raised:
$77M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
